 Thromboxane synthetase inhibition polymorphonuclear leukocyte activation hindlimb ischemia Ischemia extremity pulmonary leukostasis pulmonary artery pressure Thromboxane TX mediator process effect TX synthetase inhibitor polymorphonuclear leukocyte PMN production superoxide anion ferricytochrome reduction Fourteen dogs hours bilateral gracilis muscle ischemia hour reperfusion production PMNs PMNs opsonized zymosan OZ mg/ml drug treatment baseline reperfusion control groups Serum TX levels radioimmunoassay reperfusion TX levels treated group control group pg/ml pg/ml Superoxide production PMNs treated group nmol nmol resting state nmol nmol stimulation production control group reperfusion baseline samples increase treatment TX synthetase inhibition activation PMNs hindlimb ischemia